Medica Group announces Dr Stuart Quin to its Board of Directors as CEO

– UK, Hastings –  Medica Group Plc (LON: MGP), the UK market leader in the provision of teleradiology services, announces that Dr Stuart Quin has been appointed as Chief Executive Officer. Dr Quin will join Medica and its Board of Directors on 1 September 2019. John Graham will remain as Chief Executive Officer until Dr Quin joins the company ensuring a smooth transition.

Stuart will join Medica from Synlab, the international laboratory diagnostic services provider, where he is currently Head of Central and Eastern Europe, Middle East and Africa. Previously he was Synlab’s Group Chief Commercial Officer and Chief Executive of its UK operations. Stuart brings a track record of delivering significant growth both in the UK and internationally and has extensive experience of working in partnership with the NHS. During Stuart’s tenure in the UK he expanded the business by winning new diagnostic service contracts and through the acquisition of four companies that significantly diversified Synlab’s service offering for customers. Prior to joining Synlab, Stuart worked in private equity both as an Investment Director at August Equity and for seven years at 3i in the UK and Germany as an Associate Director focusing on investing in healthcare. Stuart also spent four years at Accenture in the US and UK as a Manager in the health and life sciences strategy consulting practice. Stuart holds a BSc (Hons) in immunology from the University of Edinburgh, a PhD in immunology from Imperial College London and an MBA from INSEAD.

Roy Davis, Chairman of Medica, commented: “I am delighted that Stuart will be joining Medica Group as Chief Executive Officer. We undertook a rigourous recruitment process and the Board believes that Stuart is ideally suited to lead Medica as we look to continue the high growth of our business both in the UK and overseas. Stuart brings extensive experience of providing a breadth of diagnostic services to the UK’s National Health Service and to independent sector customers, as well as a background in strategic leadership of an international healthcare business.”

Commenting on his appointment, Stuart Quin said: “I am honoured to have the opportunity to lead Medica through the next phase of its development. The company has a strong reputation of delivering teleradiology services to NHS trusts across the UK. I am looking forward to working with the team at Medica, to identify and execute new growth opportunities and continuing to offer the highest quality service for customers.”


MEDICA is the UK market leader in the provision of teleradiology services, providing outsourced interpretation and reporting on MRI, CT, and plain film images. The Company currently offers three primary services to hospital radiology departments: NightHawk, an out-of-hours service, routine cross-sectional reporting on MRI and CT scans, and routine plain film reporting on x-ray images.

MEDICA has developed a bespoke secure IT platform that provides market-leading linkage between a hospital’s Radiology Information System and Consultant Radiologists who contract with MEDICA. Direct RIS access ensures that the full wider patient information is available and reviewed with every report.

The Company contracts with the largest pool of consultant radiologists outside of the NHS and has been trusted to provide more than 1.3 million examinations annually across its customer base of more than 100 NHS Trusts and various private hospital groups and diagnostic imaging companies.

For more information:

- DisclaimerNews, data, and statements included in this release are intended exclusively for general information purposes. Talent4Boards does not guarantee that news is accurate or about the correct person and accepts neither liability for the consequences of the reader’s reliance, nor responsibility for the accuracy of the information. Nothing in this release should be considered for decisions about referred securities. Products and brand names may be trademarks or registered trademarks of their respective owners.